Skip to main content
. 2021 Jan 7;105(3-4):169–180. doi: 10.1159/000510407

Table 8.

Recurrence rates in studies with non-seminomatous GCT patients in cSI managed with surveillance before 1992 and after 1993 [20, 21, 35]

Reference N Therapy Recurrence rate, %
[35] 371 (total) 28.0
157 (1988–1992) lr 18.7
hr 54.5

[35] 214 (1993–2005) lr 14.2
hr 49.2

[21] 1,226 (total) 30.6
lr 12.0
hr 50.0

[20] 1,139 (total) 19.0

GCT, germ cell tumour; cSI, clinical stage I; hr, high risk; lr, low risk.